AgraFlora Organics Commences Research and Development Trials at Winnipeg Based Edibles Manufacturing Facility
VANCOUVER, British Columbia, Aug. 27, 2020 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) is pleased to announce that the Company has received a necessary CRA tax license and is now creating test cannabis edibles products through its Health Canada licensed Research and Development Lab (“R&D Lab”) within its 51,000-Square-foot fully-automated edibles manufacturing facility in Winnipeg, Manitoba (the “Edibles Facility”).
Through the Company’s Health Canada R&D license, AgraFlora has dialed in formulations for cannabis activated pectin and gelatin gummies, hard candy, and sugar-free variants.
James Fletcher, one of the founders and the operational manager of EIC stated, "As part of the R&D program, we have begun a testing project with Agilent to improve testing standards, methods,
and ensure consistent quality. Our efficient and highly automated R&D production allows us to provide a variety of sample products for our prospective clients to try for their established
On May 28, 2020 (see press release dated June 3,2020), AgraFlora submitted its site evidence package to Health Canada for a processing license. The Company is in regular contact with Health Canada and remains committed to the timeline that a processing license will be received in Q4 of 2020.
About AgraFlora Organics International Inc.
AgraFlora Organics International Inc. is a leading cannabis company building shareholder value through the development of revenue generating operating assets in the global cannabis industry. AgraFlora is focused primarily on the Canadian cannabis industry; the world’s most advanced and regulated legal cannabis market. Flagship Canadian assets include: Edibles & Infusions, a fully automated manufacturing facility in Winnipeg, MB for white-label and consumer branded edible production; Propagation Services Canada, a large-scale commercial greenhouse in Delta, BC focused on reshaping the Canadian flower market with high-potency, low cost cannabis flower, and AAA Heidelberg, a craft focused cannabis producer in London, ON. In addition, AgraFlora’s wholly owned subsidiary Farmako GmbH is scaling towards its goal of being Europe’s leading distributor of medical cannabis. Farmako currently has active distribution operations in Germany and expects to commence active operations in the United Kingdom in 2020. For more information please visit: https://agraflora.com/.